Zika Virus E Protein Alters the Properties of Human Fetal Neural Stem Cells by Modulating MicroRNA Circuitry
Overview
Authors
Affiliations
Zika virus (ZV) infects neural stem cells (NSCs) and causes quiescence in NSCs, reducing the pool of brain cells, leading to microcephaly. Despite conscientious efforts, the molecular mechanisms for ZV-mediated effects on NSCs lack clarity. This study aimed to explore the underlying mechanisms for ZV-mediated induction of quiescence in the primary cultures of human fetal neural stem cells (fNSCs). We demonstrate that expression of ZV envelope (E) protein displays maximum quiescence in human fNSCs by accumulating cells in the G0/G1 phase of the cell cycle as compared to other non-structural proteins, viz. NS2A, NS4A and NS4B. E protein induces immature differentiation by induction of pro-neuronal genes in proliferating fNSCs, induces apoptosis in differentiating fNSCs 3 days post differentiation, and disrupts migration of cells from differentiating neurospheres. In utero electroporation of mouse brain with E protein shows drastic downregulation of proliferating cells in ventricular and subventricular zone regions. Global microRNA sequencing suggests that E protein modulates miRNA circuitry. Among differentially expressed miRNAs, we found 14 upregulated and 11 downregulated miRNAs. Mir-204-3p and mir-1273g-3p directly regulate NOTCH2 and PAX3 expression, respectively, by binding to their 3'UTR. Bioinformatic analysis using GO analysis for the targets of differentially expressed miRNAs revealed enrichment of cell cycle and developmental processes. Furthermore, WNT, CCKR, PDGF, EGF, p53, and NOTCH signaling pathways were among the top enriched pathways. Thus, our study provides evidence for the involvement of ZV E protein and novel insights into the molecular mechanism through identification of miRNA circuitry. Art work depicting the effect of Zika virus E protein on human fetal neural stem cells.
The Role of Noncoding RNA in the Transmission and Pathogenicity of Flaviviruses.
Zhang X, Li Y, Cao Y, Wu Y, Cheng G Viruses. 2024; 16(2).
PMID: 38400018 PMC: 10892091. DOI: 10.3390/v16020242.
Sharma S, Majumdar A, Basu A Microbiol Spectr. 2024; 12(3):e0323823.
PMID: 38319106 PMC: 10913399. DOI: 10.1128/spectrum.03238-23.
Congenital Zika Virus Syndrome: Microcephaly and Orofacial Anomalies.
Scotto G, Massa S, Spirito F, Fazio V Life (Basel). 2024; 14(1).
PMID: 38255670 PMC: 10820182. DOI: 10.3390/life14010055.
Insights into Zika Virus Pathogenesis and Potential Therapeutic Strategies.
Camacho-Concha N, Santana-Roman M, Sanchez N, Velasco I, Pando-Robles V, Pedraza-Alva G Biomedicines. 2023; 11(12).
PMID: 38137537 PMC: 10741857. DOI: 10.3390/biomedicines11123316.
Strain Variation Can Significantly Modulate the miRNA Response to Zika Virus Infection.
Ramphan S, Chumchanchira C, Sornjai W, Chailangkarn T, Jongkaewwattana A, Assavalapsakul W Int J Mol Sci. 2023; 24(22).
PMID: 38003407 PMC: 10671159. DOI: 10.3390/ijms242216216.